Biomedical TB Research

 The causative agent of tuberculosis (TB), Mycobacterium tuberculosis, is estimated to infect one-third of the world's population and is responsible for the largest number of deaths attributable to a single infectious agent. South Africa ranks second in the world in incident cases of TB and the crisis has been heightened by the emergence and spread of drug resistant strains of Mycobacterium tuberculosis.

The Centre for Biomedical TB Research (CBTBR) is currently the only DST-NRF centre of excellence in the biomedical field and is hosted jointly by the universities of Stellenbosch, the Witwatersrand and Cape Town.

The strategic objectives of the CBTBR are to make significant contributions to the knowledge base through world-class research; to develop and evaluate new tools for controlling TB; and to develop human capital using research as a vehicle for training the next generation of researchers.

Research in the CBTBR spans the continuum from basic to applied, and falls into three main thematic areas: Mycobacterium tuberculosis physiology and metabolism of relevance to drug discovery and drug resistance; bridging the gap between basic and clinical TB research; and host responses to TB.

The CBTBR has created a wide network of regional, local and international collaborations and linkages and uses the combined knowledge and expertise as a platform for brokering information and rendering services at various levels. The CBTBR investigates new tools for the diagnosis, treatment and prevention of TB. It also supports the rollout of new diagnostic tests and plays a pivotal role in the impact of these technologies on TB in SA.

Experimental approaches that are based on a post-genomic research strategy play a particularly important role. The CBTBR also aligns with the department of science and technology's 10-year innovation plan for the years 2008 to 2018).

One of the five grand challenges in this plan is the farmer-to-pharma value chain, to strengthen the bioeconomy, which is strengthened through the CBTBR's research into TB drug discovery.

The leading role that the CBTBR has played in building partnerships with biomedical TB research groups, and with clinical TB research groups both locally and internationally, aligns fully with the plan's objectives to progress towards a knowledge-based economy.

For more information visit or contact Dr Bienyameen Baker [email protected]


Workers fight job-creation ‘mess’

Former Ekurhuleni workers argued in court that a programme promising to equip them with skills simply acted as a labour broker for the municipality

Court dissolves local municipality

Landmark judgment paves the way for South Africans to use legal system to hold councils responsible

Mabuza’s ‘distant relative’ scored big

Eskom’s woes are often because of boiler problems at its power plants. R50-billion has been set aside to fix them, but some of the contracts are going to questionable entities

ANC faction gunning for Gordhan

The ambush will take place at an NEC meeting about Eskom. But the real target is Cyril Ramaphosa

Press Releases

New-style star accretion bursts dazzle astronomers

Associate Professor James O Chibueze and Dr SP van den Heever are part of an international team of astronomers studying the G358-MM1 high-mass protostar.

2020 risk outlook: Use GRC to build resilience

GRC activities can be used profitably to develop an integrated risk picture and response, says ContinuitySA.

MTN voted best mobile network

An independent report found MTN to be the best mobile network in SA in the fourth quarter of 2019.

Is your tertiary institution is accredited?

Rosebank College is an educational brand of The Independent Institute of Education, which is registered with the Department of Higher Education and Training.

Is your tertiary institution accredited?

Rosebank College is an educational brand of The Independent Institute of Education, which is registered with the Department of Higher Education and Training.

VUT chancellor, Dr Xolani Mkhwanazi, dies

The university conferred the degree of Doctor of Science Honoris Causa on Dr Xolani Mkhwanazi for his outstanding leadership contributions to maths and science education development.

Innovate4AMR now in second year

SA's Team pill-Alert aims to tackle antimicrobial resistance by implementing their strategic intervention that ensures patients comply with treatment.

Medical students present solution in Geneva

Kapil Narain and Mohamed Hoosen Suleman were selected to present their strategic intervention to tackle antimicrobial resistance to an international panel of experts.